Back to search
FDAFDA · Food and drugs·Recall number Z-0815-2022

Revolution Apex, Revolution CT with Apex Edition

Published April 13, 2022 · Recall initiated: June 30, 2021

Summary

FDA records medical device Class II recall Z-0815-2022, published April 13, 2022 and initiated June 30, 2021. Recalling firm: GE Healthcare, LLC; Status: Ongoing; Reported quantity: 273 (51 US, 222 OUS) in total; Lot: Revolution Apex, Revolution CT with Apex Edition. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The accumulated dose is incorrectly displayed in certain situations. There are two situations that will result in the SmartStep displayed dose being inaccurately high.

What to do

FDA Mandated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GE Healthcare, LLC
Distributor
Worldwide - US Nationwide distribution.
Lot
Revolution Apex, Revolution CT with Apex Edition
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Revolution Apex, Revolution CT with Apex Edition recalled?

Yes. FDA published recall Z-0815-2022 on April 13, 2022. Reported hazard: The accumulated dose is incorrectly displayed in certain situations. There are two situations that will result in the SmartStep displayed dose being inaccurately high.

What should I do if I have this product?

FDA Mandated · Letter